ClinicalTrials.Veeva

Menu

Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101)

University of Florida logo

University of Florida

Status and phase

Terminated
Phase 3

Conditions

Leukemia
Myelodysplastic Syndromes

Treatments

Other: Diet

Study type

Interventional

Funder types

Other

Identifiers

NCT03016130
UF-HEM-007 (Other Identifier)
OCR15632 (Other Identifier)
UF-BMT-LDND-101 (Other Identifier)
IRB201700581

Details and patient eligibility

About

This is an open-label, two-arm, phase III non-inferiority trial to evaluate the safety of a liberalized hospital diet inclusive of fresh fruits and vegetables to a neutropenic diet in patients with prolonged neutropenia. Both cohorts and diets will adhere to the hygiene and common sense advice listed in the FDA-endorsed food safety guidelines.

Enrollment

217 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years or older
  • Undergoing treatment for hematologic malignancies or HSCT as outlined below:
  • Underlying diagnosis for non-HSCT patients:
  • Acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) receiving induction or reinduction chemotherapy; OR
  • Acute lymphoblastic leukemia (ALL) receiving an intensive induction chemotherapy (e.g., HyperCVAD±R, CALGB9251, Larsons protocol) with an expected duration of neutropenia of ≥7 days; OR
  • Allogeneic or autologous HSCT for any indication. For patients undergoing reduced intensity conditioning, only those regimens in which the expected neutropenia is ≥ 7 days are permitted and the patient must reside in the hospital
  • Expected duration of neutropenia of ≥ 7 days

Exclusion criteria

  • Use of anti infectives for treatment of active systemic infections within 7 days prior to initiation of study diet
  • Untreated major infection at presentation
  • Patients with uncontrolled invasive fungal infection (defined as those who have not completed at least 6 weeks of treatment; or who are symptomatic with two CT scans, at least 1 week apart showing uncontrolled disease at the time of initiation of study diet)
  • Uncontrolled HIV, Hepatitis B and C infection
  • Receipt of nutrition via enteral tube or total parenteral nutrition at the time of enrollment
  • Patients unwilling to eat fresh fruit and/or vegetables
  • Planned management of neutropenia in the outpatient setting

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

217 participants in 2 patient groups

Liberalized Hospital Diet (Diet A)
Active Comparator group
Description:
Diet A would include fresh fruits and/or fresh vegetables in a liberalized hospital diet, and subjects will be encouraged to eat at least one daily serving of fresh fruits and/or vegetables.
Treatment:
Other: Diet
Neutropenic Diet (Diet B)
Active Comparator group
Description:
Diet B is the hospital neutropenic diet.
Treatment:
Other: Diet

Trial contacts and locations

1

Loading...

Central trial contact

Alexandra Mueller

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems